Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Maggioni A et al. – This study shows that RRH is safe and feasible. However, a comparison of oncologic outcomes and cost–benefit analysis is still needed and it has to be carefully evaluated in the future.

Related Articles

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study : The Lancet Oncology
The Lancet Oncology - Online First, 10/12/09    Relevance Score: 70%

Transvaginal doppler sonography for assessment the response to radiotherapy in locally advanced squamous cervical cancer: a preliminary study
Archives of Medical Science, 11/03/09    Relevance Score: 69%

Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09    Relevance Score: 69%

A survey of the knowledge and attitude of Jordanian obstetricians and gynaecologists to cervical cancer screening
Journal of Obstetrics and Gynaecology, 10/29/09    Relevance Score: 69%

Interleukin-12 gene polymorphism and cervical cancer risk
American Journal of Clinical Oncology, 10/06/09    Relevance Score: 69%

Today in Gynecologic Oncology...keeping you current

Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09

Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09

Vaginal Schwannoma in a case with uterine myoma
Annals of Diagnostic Pathology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address